Dated research articles. Historical articles may no longer reflect current regulatory status. Check the cited primary source.
A structured review of BPC-157's mechanism, the current state of animal and human data, and dated FDA regulatory context and its verification limits.
From the 2023 bulk drug substance restrictions to RFK Jr.'s February 2026 statements — a historical overview with source-linked regulatory corrections; not a determination of current eligibility.
Here's what the human RCT data actually shows.
Semaglutide and tirzepatide were approved for metabolic indications, but the research frontier extends to neurodegeneration, addiction, and cardiac protection.
With 11 RCTs in the PubMed record, Thymosin Alpha-1 has deep human evidence in the PeptideX index. Research information is not evidence of FDA approval; check the source-linked regulatory profile.
Here's the full evidence picture — and the significant gaps that remain.
Epithalon activates telomerase, modulates melatonin synthesis, and has shown lifespan extension in multiple rodent models. The human evidence comes almost entirely from Soviet-era observational studies — here's how to read it correctly.
Animal study, human observational, RCT — these terms are frequently misused in biohacking communities. A practical guide to evaluating peptide evidence quality before drawing conclusions.